The European Commission (EC) approved Boehringer Ingelheim’s breakthrough oral anticoagulant, Pradaxa® (dabigatran etexilate) for the prevention of stroke in patients with atrial fibrillation (AF) at risk of stroke. This EU label extension means that, for the first time in over 50 years, millions of AF patients across Europe will have access to a new treatment for the prevention of AF-related strokes, which is effective and convenient, and has demonstrated a good safety profile.
05 August 2011
Convergence Pharmaceuticals today announced that the Phase II proof of concept study with CNV1014802 for treating pain associated with lumbosacral radiculopathy (LSR) has started.
19 July 2011
Cancer Research UK scientists have revealed that a ‘detox’ protein which mops up harmful ‘reactive oxygen’ in cells could also trigger pancreatic and lung cancer development, according to a study published in Nature.
06 July 2011
A global United Nations Summit on AIDS has taken a critical step by committing to reach 15 million people with HIV treatment by 2015.
13 June 2011
Six new collaborative research and development projects are set to receive nearly £6 million of government funding in the latest stage of a major five-year initiative to ensure that the UK is a world leader in the development of personalised medicine.
10 June 2011
Meningitis Research Foundation (MRF) welcomes new data released today by Novartis Vaccines and Diagnostics, revealing a robust immune response in babies, toddlers and teenagers to their new Men B vaccine candidate (4CMenB), currently submitted for licence to the EMA.
09 June 2011
A cutting-edge research project at the University of Leicester is aiming to improve the treatment of diabetes and cardiovascular diseases.
03 June 2011
ELRIG are pleased to announce that Dr Jamie Thomson, Wisconsin University, one of the world’s leading experts in stem cell biology, has been confirmed as one of the Keynote Speakers for this conference.
31 May 2011
Cancer Research UK scientists have discovered that a common gene fault in cervical cancer cells triggers a ripple of molecular signals, which makes the disease more aggressive, according to research published in The Journal of Pathology.
18 May 2011
A pioneering investigation into the treatment of cervical cancer will take place at the University of Leeds following a major advancement in the study of the disease.
17 May 2011
Today sees the launch of Palexia® SR (tapentadol prolonged release) for the oral treatment of adults with severe chronic pain, which can only be adequately managed with opioid analgesics. Palexia® SR is the first in a new class of centrally acting analgesics called MOR-NRI, which has two mechanisms of action in one molecule; both µ-opioid receptor (MOR) agonism and noradrenaline reuptake inhibition (NRI).
16 May 2011
A new, promising marker for diagnosing prostate cancer has been discovered by Uppsala researchers with the aid of a unique method developed at the Department of Immunology, Genetics and Pathology. The study, being published this week in the journal Proceedings of the National Academy of Sciences, PNAS, can lead to more reliable diagnoses and fewer unnecessary operations.
11 May 2011
A rarely prescribed asthma drug is easier to use and just as effective as conventional treatment with inhalers, according to a new study led by the University of East Anglia (UEA).
05 May 2011
Lithium treatment helps slow the progression of memory loss, according to new research, published in the British Journal of Psychiatry. The finding raises the possibility that lithium could one day be used to prevent Alzheimer’s disease.
28 April 2011
Neurophysiologists of the Istituto Italiano di Tecnologia (Iit) and the University of Genoa, together with geneticists of the Centre Hospitalier de l’Université de Montréal have demonstrated the involvement of the Synapsin-1 gene (SYN1) in epilepsy and autism.
21 April 2011
Scientists at the Babraham Institute have discovered a critical piece of the jigsaw that explains how a type of immune cell – a white blood cell known as a neutrophil – is activated by antibodies. The research, published today in the journal Science Signaling, brings new understanding to how the Phosphatidylinositol 3-kinase (PI3K) signalling pathway is used to regulate neutrophil function. This may pave the way for the development of a strategy to specifically inhibit the inappropriate activation of these immune cells that is seen in auto-immune inflammatory conditions such as rheumatoid arthritis, glomerulonephritis and some skin blistering diseases.
12 April 2011
Study shows how cells decide whether they have enough fat – a molecular checkpoint that, when disturbed, could lead to obesity or other diseases.
07 April 2011
Elsevier, the leading publisher of scientific, technical and medicalinformation products and services, today announced that the Anxiety andDepression: 21st Neuropharmacology Annual Conference will take place in Virginia, USA on 10-11 November 2011 as a satellite to the 2011 Meeting of the Society for Neuroscience.
11 March 2011
It’s not known what causes the disease or how to cure it. And the stakes have never been higher. But one European neuroscientist is leading the charge to uncover new treatments for this neurodegenerative disease.
07 March 2011
Confusing instructions on medicine bottles and packets of pills dispensed from UK pharmacies are to be replaced with simpler words and phrases from this month.
03 March 2011